Lipids
Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(543)
- Endocannabinoid/Endocannabinoid-like(145)
- Fatty Acid Conjugates(11)
- Fatty Acids(498)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(77)
- Fatty Esters/Ethers(152)
- Glycerolipids(357)
- Glycerophospholipids(272)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(146)
- Isoprostanes(36)
- Leukotrienes(69)
- Lipid Transport(11)
- Lipid-Based Drug Delivery(163)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(124)
- Other Lipid Kinases(2)
- P450
- Polyketides(71)
- Prenol Lipids(19)
- Prostaglandins(483)
- Protein Lipidation(24)
- Reactive O2/N2 Pathways(116)
- Saccharolipids(2)
- Sphingolipids(359)
- Sterol Lipids(288)
- Thromboxanes(14)
- 11β-HSD
- 17β-HSD(2)
Lipids 相关产品(3019)
- GC45155W146 (trifluoroacetate salt)CAS: 909725-62-8纯度: >98.00% / >95.00%
W146 (trifluoroacetate salt)是鞘氨醇-1-磷酸受体1（S1PR1）的选择性拮抗剂，EC 50 值为398nM。
- GC45183ZK118182 isopropyl esterCAS: 154927-31-8纯度: >98.00%
The prodrug form of a potent DP receptor agonist
- GC45207α-hydroxy Farnesyl Phosphonic AcidCAS: 148796-53-6纯度: >98.00%
A nonhydrolyzable analog of farnesyl pyrophosphate
- GC45210α-Linolenic Acid (sodium salt)CAS: 822-18-4纯度: >95.00%
An essential ω-3 polyunsaturated fatty acid
- GC45238δ14-Triamcinolone acetonideCAS: 1260149-96-9纯度: >96.00%
A potential impurity found in commercial triamcinolone acetonide preparations
- GC45250(-)-L-threo-PDMP (hydrochloride)CAS: 161491-04-9纯度: >98.00%
An enhancer of ganglioside biosynthesis
- GC45255(+)-5-trans Cloprostenol isopropyl ester纯度: >98.00%
A more lipid soluble form of (+)-5-trans cloprostenol
- GC45260(+)-Cloprostenol isopropyl esterCAS: 157283-66-4纯度: >99.50%
A more lipid soluble form of (+)-cloprostenol
- GC45263(+)-D-threo-PDMP (hydrochloride)CAS: 139889-62-6纯度: >98.00%
An inhibitor of sphingolipid biosynthesis
- GC45270(±)10(11)-EDP EthanolamideCAS: 2123484-71-7纯度: >98.00%
An ω-3 endocannabinoid epoxide and CB receptor agonist
- GC45278(±)-Ketoprofen-d3CAS: 159490-55-8纯度: >99.00%
An internal standard for the quantification of (±)-ketoprofen
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC45132 | Ursodeoxycholic Acid (sodium salt) | 2898-95-5 | >98.00% | |
A secondary bile acid | ||||
| GC45141 | Vedaprofen | 71109-09-6 | >95.00% | |
An NSAID used in animals | ||||
| GC45154 | W140 (trifluoroacetate salt) | 909725-64-0 | >95.00% | |
An inactive enantiomer of W146 | ||||
| GC45155 | W146 (trifluoroacetate salt) | 909725-62-8 | >98.00% / >95.00% | |
W146 (trifluoroacetate salt)是鞘氨醇-1-磷酸受体1（S1PR1）的选择性拮抗剂，EC 50 值为398nM。 | ||||
| GC45175 | YVAD-CHO (trifluoroacetate salt) | - | >95.00% | |
A caspase-1/ICE inhibitor | ||||
| GC45183 | ZK118182 isopropyl ester | 154927-31-8 | >98.00% | |
The prodrug form of a potent DP receptor agonist | ||||
| GC45206 | α-GalCer analog 8 | 922727-14-8 | >95.00% | |
A triazole α-GalCer derivative | ||||
| GC45207 | α-hydroxy Farnesyl Phosphonic Acid | 148796-53-6 | >98.00% | |
A nonhydrolyzable analog of farnesyl pyrophosphate | ||||
| GC45210 | α-Linolenic Acid (sodium salt) | 822-18-4 | >95.00% | |
An essential ω-3 polyunsaturated fatty acid | ||||
| GC45238 | δ14-Triamcinolone acetonide | 1260149-96-9 | >96.00% | |
A potential impurity found in commercial triamcinolone acetonide preparations | ||||
| GC45250 | (-)-L-threo-PDMP (hydrochloride) | 161491-04-9 | >98.00% | |
An enhancer of ganglioside biosynthesis | ||||
| GC45255 | (+)-5-trans Cloprostenol isopropyl ester | - | >98.00% | |
A more lipid soluble form of (+)-5-trans cloprostenol | ||||
| GC45260 | (+)-Cloprostenol isopropyl ester | 157283-66-4 | >99.50% | |
A more lipid soluble form of (+)-cloprostenol | ||||
| GC45261 | (+)-Cloprostenol methyl amide | - | >98.00% | |
Lipophilic analog of (+)-cloprostenol | ||||
| GC45262 | (+)-Cloprostenol methyl ester | 56687-85-5 | >98.00% | |
Lipophilic analog of (+)-cloprostenol | ||||
| GC45263 | (+)-D-threo-PDMP (hydrochloride) | 139889-62-6 | >98.00% | |
An inhibitor of sphingolipid biosynthesis | ||||
| GC45269 | (±)10(11)-DiHDPA | 1345275-22-0 | >98.00% | |
An epoxygenase metabolite of DHA | ||||
| GC45270 | (±)10(11)-EDP Ethanolamide | 2123484-71-7 | >98.00% | |
An ω-3 endocannabinoid epoxide and CB receptor agonist | ||||
| GC45271 | (±)11(12)-EET Ethanolamide | - | >98.00% | |
A potential cytochrome P450 metabolite of AEA | ||||
| GC45278 | (±)-Ketoprofen-d3 | 159490-55-8 | >99.00% | |
An internal standard for the quantification of (±)-ketoprofen | ||||
| GC45283 | 1,2,3-Tri-13(E)-Docosenoyl-rac-glycerol | 37635-44-2 | >98.00% | |
A triacylglycerol | ||||
| GC45284 | 1,2,3-Tri-13(Z),16(Z)-Docosadienoyl-rac-glycerol | 958760-53-7 | >98.00% | |
A triacylglycerol | ||||
| GC45285 | 1,2,3-Trihexanoyl-rac-glycerol | 621-70-5 | >95.00% | |
A triacylglycerol | ||||
| GC45286 | 1,2,3-Tripentadecanoyl-rac-glycerol | 7370-46-9 | >98.00% | |
A triacylglycerol | ||||